Skin Cancer

Saving Our Skin: A Surgeon’s Story of Tenacity, Adventure and Giving Back

Dermatology News

Derm Community

To celebrate the 40th birthday of The Skin Cancer Foundation, Dr. Robins is donating proceeds from all sales of his memoir to the Foundation he founded in 1979.

Learn More

Saving Our Skin: A Surgeon’s Story of Tenacity, Adventure and Giving Back, by Perry Robins, MD

In his new book, JDD Founder, Dr. Perry Robins, details how he upended conventional wisdom in the medical community by showing dermatologists that they could be skin cancer surgeons.

Perry Robins, MD, saved our skin — literally. The world-renowned surgeon took on an enemy of unimaginable power: the sun. At a time when most people worshipped a sun-kissed glow, the medical techniques and messages Dr. Robins promoted had the power to affect every human being on the planet.

Born in Newark during the Great Depression, Perry Robins never had it easy, but he always made the best of it. Struggling in school with dyslexia and grueling part-time jobs, being drafted by the Army and sent overseas—none of the obstacles life threw his way could slow him down.

After his medical training from Germany to NYU, Dr. Robins studied a type of skin cancer surgery invented by Frederic Mohs, MD, at the University of Wisconsin. He brought the technique back to NYU and established the first fellowship program in Mohs surgery. Despite resistance, Dr. Robins upended conventional wisdom in the medical community by showing dermatologists that they could be skin cancer surgeons.

He took on skin cancer at a time when few people were aware of it, and when fashion dictated a “deep, dark, sexy” tan. He taught Mohs surgery, now the gold standard of treatment, to physicians in the U.S. and around the world. He created international alliances as well as the first charitable foundation devoted to educating people about skin cancer, using his own hard-earned money. He cured cancers (47,000 of them in his 40-plus years of practice at NYU), changed people’s perceptions about the sun and made friends all over the world as a professor, entrepreneur and philanthropist.

“Written with warmth and humor, this memoir documents the amazing story of Perry Robins, MD, from a humble beginning in New Jersey to becoming a world-class surgeon who cured cancers and changed the world for the better. Readers will be inspired by his enormous energy, curiosity, larger-than-life personality and keen vision for the future —and will have a rollicking good time along the way!” — C. William Hanke, MD, Mohs surgeon in Indianapolis who has served as president of 13 professional societies

To celebrate the 40th birthday of The Skin Cancer Foundation, Dr. Robins is donating proceeds from all sales of his memoir to the Foundation he founded in 1979.

Get Your Copy Today

Saving Our Skin: A Surgeon’s Story of Tenacity, Adventure and Giving Back, by Perry Robins, MD

You May Also Like

Journal of Drugs in Dermatology JDD featuring Treatment Adherence in Patients With Acne Vulgaris: A Narrative ReviewAcneFeatured ArticlesLatest NewsTreatment Adherence in Patients With Acne Vulgaris: A Narrative Review
September 18, 2026

Treatment Adherence in Patients With Acne Vulgaris: A Narrative Review

Unlocking the Adherence Puzzle in Acne Management  Have you read this latest insightful review from the Journal of Drugs in Dermatology (JDD)? Acne vulgaris remains one of the most frequent…
Journal of Drugs in Dermatology JDD featuring JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort StudyFeatured ArticlesLatest NewsJAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort Study
September 17, 2026

JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort Study

Targeting Fibroproliferative Disorders: Could JAK Inhibitors Lower Keloid and Hypertrophic Scar Risk?  Here is an essential new report from the JDD that could shift how we think about scar prevention.…
Journal of Drugs in Dermatology JDD featuring our current Author Spotlight features Jessica L. Feig MD PhD, one of the co-authors of JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort StudyAuthor SpotlightFeatured ArticlesLatest NewsAuthor Spotlight: Jessica L. Feig MD PhD
September 15, 2026

Author Spotlight: Jessica L. Feig MD PhD

Check Out JDD’s Latest Author Spotlight  Our current Author Spotlight features Jessica L. Feig MD PhD, one of the co-authors of JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic…

Leave a Reply